Insulin Human recalls

The FDA has published 1 recall involving Insulin Human since 2026. The latest was reported on 9 Sep 2026. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2026

Last 12 months1reported

Class I00% of total

Ongoing1latest 9 Sep 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 1

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why insulin human is recalled

Manufacturing (CGMP) Deviations1100%

Companies

Baxter Healthcare1100%

By year

20261100%

Ongoing insulin human recalls

1 active

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	Myxredlin, Insulin Human in 0.9% Sodium Chloride Injection/mL) recalledMyxredlin	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide

All insulin human recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
9 Sep 2026Drug	CLASS II	Myxredlin, Insulin Human in 0.9% Sodium Chloride Injection/mL) recalledMyxredlin	Baxter Healthcare	Manufacturing (CGMP) Deviations	Nationwide

Should you stop taking Insulin Human?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.